JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 28 No. 8 1294-1302
© 1987 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hnatowich, D.J.
Right arrow Articles by Rusckowski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hnatowich, D.J.
Right arrow Articles by Rusckowski, M.

Investigations of Avidin and Biotin for Imaging Applications

D.J. Hnatowich, F. Virzi and M. Rusckowski

Department of Nuclear Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts

Correspondence: For reprints contact: D.J. Hnatowich, PhD, Dept. of Nuclear Medicine, University of Massachusetts Medical Center, Worcester, MA 01605.

ABSTRACT

The attractive properties of avidin (streptavidin) and biotin, in particular their strong affinities (Kd = 10–15M), may be used to advantage in imaging applications. These molecules have been used in this preliminary investigation to improve the targeting of 111In in animals. Antibodies have been conjugated with biotin and administered unlabeled while, at a later time, the radiolabel was administered attached to DTPA-coupled avidin or streptavidin. An alternative procedure was also considered whereby the antibodies were conjugated with avidin and administered before the administration of radiolabeled biotin. Using a model in which the target consisted of conjugated agarose beads deposited in the peritoneum of mice, it has been shown that the target/nontarget radioactivity ratios may be significantly improved with respect to the conventional procedures through the use of this approach.




This article has been cited by other articles:


Home page
BloodHome page
A. Pantelias, J. M. Pagel, N. Hedin, L. Saganic, S. Wilbur, D. K. Hamlin, D. S. Wilbur, Y. Lin, D. Stone, D. Axworthy, et al.
Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas
Blood, June 1, 2007; 109(11): 4980 - 4987.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Liu, S. Dou, G. Mardirossian, J. He, S. Zhang, X. Liu, M. Rusckowski, and D. J. Hnatowich
Successful Radiotherapy of Tumor in Pretargeted Mice by 188Re-Radiolabeled Phosphorodiamidate Morpholino Oligomer, a Synthetic DNA Analogue.
Clin. Cancer Res., August 15, 2006; 12(16): 4958 - 4964.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. M. Goldenberg, R. M. Sharkey, G. Paganelli, J. Barbet, and J.-F. Chatal
Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
J. Clin. Oncol., February 10, 2006; 24(5): 823 - 834.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. J. Forster, E. B. Santos, P. M. Smith-Jones, P. Zanzonico, and S. M. Larson
Pretargeted Radioimmunotherapy with a Single-Chain Antibody/Streptavidin Construct and Radiolabeled DOTA-Biotin: Strategies for Reduction of the Renal Dose
J. Nucl. Med., January 1, 2006; 47(1): 140 - 149.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. M. Sharkey, H. Karacay, T. M. Cardillo, C.-H. Chang, W. J. McBride, E. A. Rossi, I. D. Horak, and D. M. Goldenberg
Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods
Clin. Cancer Res., October 1, 2005; 11(19): 7109s - 7121s.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. M. Sharkey and D. M. Goldenberg
Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
J. Nucl. Med., January 1, 2005; 46(1_suppl): 115S - 127S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. He, G. Liu, S. Gupta, Y. Zhang, M. Rusckowski, and D. J. Hnatowich
Amplification Targeting: A Modified Pretargeting Approach with Potential for Signal Amplification--Proof of a Concept
J. Nucl. Med., June 1, 2004; 45(6): 1087 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. M. Cardillo, H. Karacay, D. M. Goldenberg, D. Yeldell, C.-H. Chang, D. E. Modrak, R. M. Sharkey, and D. V. Gold
Improved Targeting of Pancreatic Cancer: Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy
Clin. Cancer Res., May 15, 2004; 10(10): 3552 - 3561.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. S. Akhtar, J. Iqbal, M. A. Khan, J. Irfanullah, M. Jehangir, B. Khan, I. ul-Haq, G. Muhammad, M. A. Nadeem, M. S. Afzal, et al.
99mTc-Labeled Antimicrobial Peptide Ubiquicidin (29-41) Accumulates Less in Escherichia coli Infection than in Staphlococcus aureus Infection
J. Nucl. Med., May 1, 2004; 45(5): 849 - 856.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
N.-K. V. Cheung, S. Modak, Y. Lin, H. Guo, P. Zanzonico, J. Chung, Y. Zuo, J. Sanderson, S. Wilbert, L. J. Theodore, et al.
Single-Chain Fv-Streptavidin Substantially Improved Therapeutic Index in Multistep Targeting Directed at Disialoganglioside GD2
J. Nucl. Med., May 1, 2004; 45(5): 867 - 877.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S.-M. Chye, S.-R. Lin, Y.-L. Chen, L.-Y. Chung, and C.-M. Yen
Immuno-PCR for Detection of Antigen to Angiostrongylus cantonensis Circulating Fifth-Stage Worms
Clin. Chem., January 1, 2004; 50(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. M. Sharkey, H. Karacay, H. Richel, W. J. McBride, E. A. Rossi, K. Chang, D. Yeldell, G. L. Griffiths, H. J. Hansen, and D. M. Goldenberg
Optimizing Bispecific Antibody Pretargeting for Use in Radioimmunotherapy
Clin. Cancer Res., September 1, 2003; 9(10): 3897S - 3913.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Artemov, N. Mori, R. Ravi, and Z. M. Bhujwalla
Magnetic Resonance Molecular Imaging of the HER-2/neu Receptor
Cancer Res., June 1, 2003; 63(11): 2723 - 2727.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Zhang, Z. Zhang, K. Garmestani, J. Schultz, D. B. Axworthy, C. K. Goldman, M. W. Brechbiel, J. A. Carrasquillo, and T. A. Waldmann
Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts
PNAS, February 18, 2003; 100(4): 1891 - 1895.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. M. Sharkey, W. J. McBride, H. Karacay, K. Chang, G. L. Griffiths, H. J. Hansen, and D. M. Goldenberg
A Universal Pretargeting System for Cancer Detection and Therapy Using Bispecific Antibody
Cancer Res., January 15, 2003; 63(2): 354 - 363.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. G. Garcia and R. A. Miller
Age-Dependent Defects in TCR-Triggered Cytoskeletal Rearrangement in CD4+ T Cells
J. Immunol., November 1, 2002; 169(9): 5021 - 5027.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Zhang, Z. Yao, K. Garmestani, D. B. Axworthy, Z. Zhang, R. W. Mallett, L. J. Theodore, C. K. Goldman, M. W. Brechbiel, J. A. Carrasquillo, et al.
Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha -emitting radionuclide, bismuth 213
Blood, June 17, 2002; 100(1): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C.-H. Chang, R. M. Sharkey, E. A. Rossi, H. Karacay, W. McBride, H. J. Hansen, J.-F. Chatal, J. Barbet, and D. M. Goldenberg
Molecular Advances in Pretargeting Radioimunotherapy with Bispecific Antibodies
Mol. Cancer Ther., May 1, 2002; 1(7): 553 - 563.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Liu, K. Mang'era, N. Liu, S. Gupta, M. Rusckowski, and D. J. Hnatowich
Tumor Pretargeting in Mice Using 99mTc-Labeled Morpholino, a DNA Analog
J. Nucl. Med., March 1, 2002; 43(3): 384 - 391.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. W. Press, M. Corcoran, K. Subbiah, D. K. Hamlin, D. S. Wilbur, T. Johnson, L. Theodore, E. Yau, R. Mallett, D. L. Meyer, et al.
A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts
Blood, October 15, 2001; 98(8): 2535 - 2543.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
W. Simpson, T. Olczak, and C. A. Genco
Characterization and Expression of HmuR, a TonB-Dependent Hemoglobin Receptor of Porphyromonas gingivalis
J. Bacteriol., October 15, 2000; 182(20): 5737 - 5748.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. N. Maquelin, R. Nieuwland, E. G. W. M. Lentjes, A. N. Boing, B. Mochtar, L. Eijsman, and A. Sturk
Aprotinin administration in the pericardial cavity does not prevent platelet activation
J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 552 - 557.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. R. Muzykantov, M. Christofidou-Solomidou, I. Balyasnikova, D. W. Harshaw, L. Schultz, A. B. Fisher, and S. M. Albelda
Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): A strategy for vascular immunotargeting of drugs
PNAS, March 2, 1999; 96(5): 2379 - 2384.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
X. Wu, J. E. Mogford, S. H. Platts, G. E. Davis, G. A. Meininger, and M. J. Davis
Modulation of Calcium Current in Arteriolar Smooth Muscle by alpha vbeta 3 and alpha 5beta 1 Integrin Ligands
J. Cell Biol., October 5, 1998; 143(1): 241 - 252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. H. Percy, R. Burakoff, K. Rose, H. P. Desai, C. Pothoulakis, and R. Eglow
In vitro evidence that rabbit distal colonic muscularis mucosae has a Clostridium difficile toxin A receptor
Am J Physiol Gastrointest Liver Physiol, September 1, 1998; 275(3): G402 - G409.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. N. Maquelin, R. J. Berckmans, R. Nieuwland, M. C. L. Schaap, K. ten Have, L. Eijsman, and A. Sturk
Disappearance of glycoprotein Ib from the platelet surface in pericardial blood during cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1160 - 1165.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Nieuwland, R. J. Berckmans, R. C. Rotteveel-Eijkman, K. N. Maquelin, K. J. Roozendaal, P. G. M. Jansen, K. t. Have, L. Eijsman, C. E. Hack, and A. Sturk
Cell-Derived Microparticles Generated in Patients During Cardiopulmonary Bypass Are Highly Procoagulant
Circulation, November 18, 1997; 96(10): 3534 - 3541.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H.-J. Kuo, C. L. Maslen, D. R. Keene, and R. W. Glanville
Type VI Collagen Anchors Endothelial Basement Membranes by Interacting with Type IV Collagen
J. Biol. Chem., October 17, 1997; 272(42): 26522 - 26529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. Beck-Schimmer, R. C. Schimmer, R. L. Warner, H. Schmal, G. Nordblom, C. M. Flory, M. E. Lesch, H. P. Friedl, D. J. Schrier, and P. A. Ward
Expression of Lung Vascular and Airway ICAM-1 after Exposure to Bacterial Lipopolysaccharide
Am. J. Respir. Cell Mol. Biol., September 1, 1997; 17(3): 344 - 352.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1987 by the Society of Nuclear Medicine.